Implantable Device Tachyarrhythmia Classification via Diagnostic Pacing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable medical devices (IMDs) face challenges in accurately distinguishing between different types of tachyarrhythmias and delivering appropriate therapies, often resulting in inappropriate treatments due to overlapping heart rates and rhythms.
Innovation Solution
The implementation of an IMD configured to apply supraventricular tachycardia (SVT) rejection rules to classify heart rhythms, followed by diagnostic/therapeutic pacing to differentiate between SVT and ventricular tachycardia (VT)/ventricular fibrillation (VF) rhythms, ensuring appropriate therapy is administered.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If heart rate alone is used to discriminate tachyarrhythmias, then the detection process is simple, but the classification accuracy is insufficient leading to inappropriate therapies
Solution Approach 1:
The patent segments the tachyarrhythmia detection process into multiple independent analysis dimensions: heart rate monitoring, rhythm pattern analysis, AV relationship assessment, and response to pacing maneuvers. Each dimension independently evaluates specific characteristics, and their combined results enable accurate classification without requiring a single complex detection system.
2Reliability
If sophisticated algorithms are used to distinguish SVT from VT/VF, then the therapy appropriateness is improved, but the device complexity and operational difficulty increase
Solution Approach 1:
The device performs self-diagnosis through automated analysis of multiple parameters including heart rate, rhythm patterns, and AV relationship. The system automatically executes pacing maneuvers and interprets the responses to classify arrhythmias, eliminating the need for manual interpretation by operators while ensuring reliable and appropriate therapy delivery.
3Measurement precision
If multiple criteria are monitored simultaneously for arrhythmia identification, then the detection comprehensiveness is improved, but the processing time and complexity increase
Solution Approach 1:
The device continuously monitors and pre-processes multiple parameters including heart rate, rhythm patterns, and AV relationship in the background. When a potential arrhythmia is detected, the classification algorithm already has pre-computed data ready, enabling rapid identification and therapy delivery without requiring time-consuming real-time analysis of all parameters simultaneously.
Data Source
AI summary
An implantable medical device (IMD) and methods of operating the same to treat a tachyarrhythmia are disclosed herein. In accordance with this method, an arrhythmia of the heart is classified based on one or more supraventricular tachycardia (SVT) rejection rules, which differentiate between a first group of heart rhythms that do not require treatment and a second group of heart rhythms that possibly require treatment. Diagnostic/therapeutic pacing can then be performed to further discriminate the second group of heart rhythms as being within a first sub-group of heart rhythms and a second sub-group of heart rhythms which are to be treated by applying a ventricular tachycardia (VT)/ventricular fibrillation (VF) therapy sequence. In another implementation, the order in which the IMD performs diagnostic/therapeutic pacing and analyzes passive detection and classification criteria can be reversed.